These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 19669399

  • 1. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I.
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [Abstract] [Full Text] [Related]

  • 2. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B, Lip GY.
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [Abstract] [Full Text] [Related]

  • 3. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Expert Opin Drug Saf; 2010 Jan 20; 9(1):189-99. PubMed ID: 20001756
    [Abstract] [Full Text] [Related]

  • 5. Dronedarone.
    Tamargo J, López-Farré A, Caballero R, Delpón E.
    Drugs Today (Barc); 2011 Feb 20; 47(2):109-33. PubMed ID: 21431100
    [Abstract] [Full Text] [Related]

  • 6. Dronedarone: an overview.
    Kozlowski D, Budrejko S, Lip GY, Mikhailidis DP, Rysz J, Raczak G, Banach M.
    Ann Med; 2012 Feb 20; 44(1):60-72. PubMed ID: 21745093
    [Abstract] [Full Text] [Related]

  • 7. Dronedarone: a review of characteristics and clinical data.
    Baroletti S, Catella J, Ehle M, Cheng JW.
    Crit Pathw Cardiol; 2010 Jun 20; 9(2):94-101. PubMed ID: 20520217
    [Abstract] [Full Text] [Related]

  • 8. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
    Schweizer PA, Becker R, Katus HA, Thomas D.
    Drug Des Devel Ther; 2011 Jan 06; 5():27-39. PubMed ID: 21267357
    [Abstract] [Full Text] [Related]

  • 9. Dronedarone: current evidence and future questions.
    Schafer JA, Kjesbo NK, Gleason PP.
    Cardiovasc Ther; 2010 Jan 06; 28(1):38-47. PubMed ID: 20074258
    [Abstract] [Full Text] [Related]

  • 10. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF.
    J Am Coll Cardiol; 2009 Sep 15; 54(12):1089-95. PubMed ID: 19744618
    [Abstract] [Full Text] [Related]

  • 12. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ, Schmitt J, Hohnloser SH.
    J Cardiovasc Pharmacol Ther; 2010 Dec 15; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [Abstract] [Full Text] [Related]

  • 13. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA, Salvetti M.
    Ther Adv Cardiovasc Dis; 2010 Jun 15; 4(3):155-64. PubMed ID: 20418270
    [Abstract] [Full Text] [Related]

  • 14. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D, Cheng-Lai A.
    Cardiol Rev; 2009 Jun 15; 17(5):230-4. PubMed ID: 19690474
    [Abstract] [Full Text] [Related]

  • 15. Dronedarone--a new alternative for management of atrial fibrillation.
    Hundal M, Garg RK.
    Recent Pat Cardiovasc Drug Discov; 2010 Jan 15; 5(1):47-53. PubMed ID: 20001929
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Rosa GM, Bianco D, Parodi A, Valbusa A, Zawaideh C, Bizzarri N, Ferrero S, Brunelli C.
    Expert Opin Drug Metab Toxicol; 2014 Dec 15; 10(12):1751-64. PubMed ID: 25349898
    [Abstract] [Full Text] [Related]

  • 17. Drug safety evaluation of dronedarone in atrial fibrillation.
    De Ferrari GM, Dusi V.
    Expert Opin Drug Saf; 2012 Nov 15; 11(6):1023-45. PubMed ID: 22971242
    [Abstract] [Full Text] [Related]

  • 18. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L, Audureau E, Takeda A, Jarzebowski W, Belmin J, Lafuente-Lafuente C.
    Cochrane Database Syst Rev; 2019 Sep 04; 9(9):CD005049. PubMed ID: 31483500
    [Abstract] [Full Text] [Related]

  • 19. Impact of dronedarone in atrial fibrillation and flutter on stroke reduction.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Clin Interv Aging; 2010 Apr 07; 5():63-9. PubMed ID: 20396635
    [Abstract] [Full Text] [Related]

  • 20. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT, Ehrlich JR, Hohnloser SH.
    J Cardiovasc Electrophysiol; 2006 Sep 07; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.